Skip to main content
OptiNose, Inc. (OPTN)
NASDAQ: OPTN · IEX Real-Time Price · USD
0.860
-0.045 (-4.93%)
At close: Apr 26, 2024, 4:00 PM
0.867
+0.007 (0.77%)
After-hours: Apr 26, 2024, 7:52 PM EDT

OptiNose Revenue

In the year 2023, OptiNose had annual revenue of $70.99M, a decrease of -6.93%. Revenue in the quarter ending December 31, 2023 was $19.87M, a -4.75% decrease year-over-year.

Revenue (ttm)
$70.99M
Revenue Growth
-6.93%
P/S Ratio
1.37
Revenue / Employee
$537,780
Employees
132
Market Cap
96.93M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202370.99M-5.29M-6.93%
Dec 31, 202276.28M1.62M2.18%
Dec 31, 202174.65M25.54M51.99%
Dec 31, 202049.12M14.49M41.83%
Dec 31, 201934.63M27.57M390.18%
Dec 31, 20187.07M--
Dec 31, 20170--
Dec 31, 201647.50M47.42M55,782.35%
Dec 31, 201585.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 1.05B
Sangamo Therapeutics 176.23M
FibroGen 147.75M
Neuronetics 71.35M
KORU Medical Systems 28.52M
Adagene 18.11M
Envoy Medical 316.00K
Revenue Rankings

OPTN News

More News